Print
23 January 2018
GMP News
The exports of Russian medical products will be one of the main areas of activities in the next decade, said Sergey Tsyb, the Deputy Minister of Industry and Trade of the Russian Federation.
“As for the exports of medical products, this will be one of the main areas of activities in the next ten years and beyond,” said Mr. Tsyb speaking at the Gaidar forum.
He added that this area will receive a particular attention in Pharma 2030 program, which will replace the current Pharma 2020 program.
“The program implies… the maximum assistance to exports of Russian products. We see that this includes not only the products manufactured at the Russian plants; it includes the products manufactured today at localized sites,” said Mr. Tsyb.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.